LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Evaluation of commercially available immuno‐magnetic agglutination in comparison to enzyme‐linked immunosorbent assays for rapid point‐of‐care diagnostics of COVID‐19

Photo from wikipedia

Coronavirus disease 2019 (COVID‐19) is caused by Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). Fast, accurate, and simple blood‐based assays for quantification of anti‐SARS‐CoV‐2 antibodies are urgently needed to identify infected… Click to show full abstract

Coronavirus disease 2019 (COVID‐19) is caused by Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). Fast, accurate, and simple blood‐based assays for quantification of anti‐SARS‐CoV‐2 antibodies are urgently needed to identify infected individuals and keep track of the spread of disease.

Keywords: magnetic agglutination; agglutination comparison; available immuno; evaluation commercially; immuno magnetic; commercially available

Journal Title: Journal of Medical Virology
Year Published: 2021

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.